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Localization of the MP1-MAPK Scaffold Complex
to Endosomes Is Mediated by p14
and Required for Signal Transduction
through the MAPK cascade (Di Fiore and Gill, 1999).
A critical step in distinguishing between recycling and
degradation of the EGFR occurs at the late endosome.
Proper sorting at the late endosomal compartment re-
quires the kinase activity of the EGFR, sorting signals
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Austria in its cytoplasmic tail and the ubiquitin ligase c-Cbl
2Institute for Anatomy, Histology and Embryology (Felder et al., 1990; Futter et al., 1996; Gruenberg and
Department of Histology and Molecular Cell Biology Maxfield, 1995). Perturbations of sorting result in signal
University of Innsbruck amplification in the ERK pathway, thereby contributing
Muellerstrasse 59 to tumorigenesis (Joazeiro et al., 1999; Levkowitz et al.,
A-6020 Innsbruck 1998; Waterman et al., 1999). On the one hand, it is clear
Austria that the endosomal system has a critical function in the
degradation of the activated EGFR. On the other hand,
there is an emerging body of evidence suggesting that
Summary the endosomal system additionally serves as intracellu-
lar site for the initiation and regulation of signal transduc-
Eukaryotic cells use the extracellular signal regulated tion (Cavalli et al., 2001; Ceresa and Schmid, 2000; Di
kinase (ERK) cascade to connect cell-surface recep- Fiore and De Camilli, 2001). In agreement with this con-
tors to intracellular targets. Although various signals cept, it has been demonstrated that the EGFR maintains
are routed through the ERK pathway, cells respond its activity in the endosomal system until it is finally
accordingly to a given stimulus. To regulate proper taken up into the lumen of the lysosome and degraded
signal transduction, scaffolds and adaptors are em- (Burke et al., 2001; Wouters and Bastiaens, 1999). Impor-
ployed to organize specific signaling units. The scaf- tantly, it appears that the internalization of the activated
fold protein MP1 (MEK1 partner) assembles a scaffold EGFR from the plasma membrane into the endosomal
complex in the ERK cascade. We show that p14 func- compartment is required for the full activation of MAPK
tions as an adaptor protein, which is required and
signaling (Kranenburg et al., 1999; Vieira et al., 1996).
sufficient to localize MP1 to endosomes. Reduction of
Adaptor proteins like Grb and Shc, which recruit the
MP1 or p14 protein levels by siRNAi results in defective
guanine nucleotide exchange factor, SOS, to finally acti-
signal transduction. Therefore, our results suggest
vate Ras are associated with the activated EGFR on thethat the endosomal localization of the p14/MP1-MAPK
membranes of the endosomal system (Jiang and Sorkin,scaffold complex is crucial for signal transduction.
2002; Sorkin et al., 2000). Consistently, Ras is not only
active at the plasma membrane but also on endosomesIntroduction
(Jiang and Sorkin, 2002; Mochizuki et al., 2001). Only
recently has it also been shown that activated MAPKThe evolutionarily conserved mitogen-activated protein
localizes to internal membranes, thereby creating sig-kinase (MAPK) cascades are involved in the regulation
naling endosomes (Howe et al., 2001; Luttrell et al., 2001;of cell growth, differentiation, and survival. At least five
Wu et al., 2001). Taken together, these data suggest thatgroups of MAPK pathways are distinguished in mam-
signal transduction from the EGFR to the ERK pathwaymals, one of which is the Ras/Raf/MEK (mitogen-acti-
occurs at the plasma membrane but, also, notably, invated protein kinase/ERK kinase)/ERK (extra-cellular
the endocytic compartment. However, molecular mech-signal regulated kinase) pathway. The central element
anisms that link MAPK signaling to endosomes are notof the ERK pathway is a three-kinase module, consisting
understood.of Raf, MEK and ERK. Signal transduction through the
MAPK pathways are used to transmit various signals,ERK cascade is initiated by the activation of Raf through
which result in different biological responses. Therefore,the small G protein Ras (for review, see Chang and Karin,
signaling through the cascades has to be specified. The2001; Kolch, 2000; Pawson and Scott, 1997; Schaeffer
specificity of the signals conducted by the MAPK cas-and Weber, 1999).
cades can be achieved by organizing the kinases intoUpon activation at the plasma membrane, receptor
multi-protein complexes (Pawson and Scott, 1997).tyrosine kinases (RTKs) such as the epidermal growth
Scaffold proteins are used to organize specific signalingfactor receptor (EGFR) activate Ras and thereby initiate
units. Additionally, adaptors localize scaffold complexessignal transduction through the ERK pathway. The acti-
to distinct subcellular compartments to ensure specific-vated EGFR also initiates events leading to its endocyto-
ity and spatial as well as temporal regulation of signalsis (Lamaze and Schmid, 1995). Internalized receptors
are delivered to the endosomal system, from which they transduction (Garrington and Johnson, 1999; Kolch,
are either recycled to the cell surface or sorted to lyso- 2000).
somes for degradation (Lemmon and Traub, 2000). Deg- Studies in Saccharomyces cerevisiae have estab-
radation of the activated EGFR attenuates the signaling lished that the Ste5p scaffold organizes and localizes
the enzymatic components of the mating-MAPK path-
way (Choi et al., 1994). Ste5p-mediated organization and3Correspondence: lukas.a.huber@uibk.ac.at
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compartmentalization of signal transduction is neces-
sary for Saccharomyces cerevisiae to respond accord-
ingly to a pheromone stimulus (Feng et al., 1998;
Whiteway et al., 1995).
The use of scaffold proteins is also common in the
MAPK cascades of higher eukaryotes. In the ERK path-
way, KSR (Kinase suppressor of Ras) and MP1 (MEK1
partner) serve as scaffold proteins to regulate signal
transduction. KSR mediates the interaction between Raf
and MEK (Muller et al., 2001; Roy et al., 2002; Roy and
Therrien, 2002). MP1 specifically binds to MEK1, but
not to MEK2, and thereby facilitates the activation of
extracellular signal regulated kinase 1 (ERK1) (Schaeffer
et al., 1998). The existence of adaptor proteins that con-
trol the localization of KSR or MP1 would additionally
provide flexibility in regulating the efficiency and the
specificity of the MAPK cascade (Schaeffer et al., 1998;
Schaeffer and Weber, 1999). Recently, it has been dem-
onstrated that C-TAK1 regulates the localization of KSR
in response to EGF stimulation (Muller et al., 2001).
In a previous report, we have identified a highly con-
served protein of 14 kDa copurifying with late endo-
somes/lysosomes on density gradients. We found that
this protein, termed p14, is peripherally associated with
the cytoplasmic face of late endosomes. Additionally,
we have shown that p14 interacts with MP1 on late
endosomes in a variety of different cell types (Wunder-
lich et al., 2001).
Now, we show that p14 and MP1 are crucial for effi-
cient EGF-induced signaling in the ERK pathway. p14
is required and sufficient for the localization of MP1
to late endosomes. Thus, p14 acts as an endosomal
adaptor protein for MP1. Furthermore, our data suggest
that the endosomal localization of the p14/MP1-MAPK
scaffold complex is required for efficient signaling in the
ERK cascade.
Results
Figure 1. p14 Enhances EGF-Induced MAP Kinase Signaling
p14 Enhances EGF-Induced MAPK Signaling
(A) Hela cells expressing Xpress-tagged p14 (Xp14) were either left
We have shown that p14 binds to the MAPK-scaffold starved or stimulated for 10 min with EGF. Cell lysates were sepa-
protein MP1 (Wunderlich et al., 2001). To test if p14 rated by SDS-PAGE and probed with the indicated antibodies.
would have a regulatory function in EGF-induced MAPK (B) A stable Elk1-driven luciferase reporter Hela cell line was tran-
siently transfected to express increasing amounts of Xp14. Cellssignaling, we first overexpressed p14 in Hela cells. As
were stimulated for 10 min with EGF, prior to lysis. One aliquot ofshown in Figure 1A, overexpression of p14 resulted in
the cell extracts was used to measure the Luciferase activity. Thehigher levels of endogenous activated (phosphorylated)
other aliquot was used to monitor the expression of Xp14 by immu-
ERK1/2 upon EGF stimulation. Next, we asked whether noblotting. DNA constructs were transfected at the following con-
the enhanced activation of ERK1/2 by p14 in response centrations: lane 1: empty vector 400 ng; lane 2: empty vector 400
to EGF would also affect nuclear signaling. Elk-1 is a ng, lane3; Xp14 100 ng, lane 4: Xp14 200 ng; lane 5: Xp14 400 ng
(corresponds to the expression of Xp14 in [A]).nuclear down-stream target of activated ERK1/2 (Whit-
marsh et al., 1995). Therefore, we transiently overex-
pressed increasing amounts of p14 in a stable Elk-1 p14 and MP1 Are Both Required
driven luciferase reporter cell line. Increasing amounts for ERK1/2 Signaling
of ectopic p14 significantly enhanced the EGF-induced If p14 is crucial for EGF-induced MAP kinase signaling,
MAP kinase activity, in a concentration-dependent man- depletion of endogenous p14 protein levels should af-
ner (Figure 1B). High levels of p14 expression caused a fect EGF-induced MAP kinase activity. To address this
significant enhancement not only of the ERK1/2 activa- question we used the siRNAi technique to reduce the
tion (Figure 1A), but also of the ERK1/2 activity toward amounts of endogenous p14 protein (Elbashir et al.,
the downstream effector Elk1 (Figure 1B). Expression 2001). Two p14 siRNAs oligonucleotides (p14 siRNA1
of green fluorescent protein (GFP) had no effect on MAP and p14 siRNA2), complementary to two different re-
kinase signaling (data not shown). We concluded that gions of the human p14 mRNA, were used to reduce
p14 has the potential to enhance EGF-induced MAPK endogenous p14 protein levels in Hela cells. Upon trans-
fection, p14 siRNA2 strongly decreased the amountssignaling.
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Figure 2. p14 and MP1 Are Essential for EGF-
Induced MAP Kinase Signaling in Cells
(A) The oligonucleotide p14 siRNA1 and p14
siRNA2 against p14 were used to reduce the
protein levels of endogenous p14 in Hela
cells. Control cells were treated with single-
stranded sense RNA. The efficiency of the
knock down was monitored by p14 immu-
noblot analysis with anti-p14 antibody. Cell
lysates were separated by SDS-PAGE and
probed with the indicated antibodies.
(B) Hela cells, treated with p14 siRNA1, p14
siRNA2, and control sense RNA, respectively,
were either left starved or stimulated with
EGF for 10 min prior to lysis. Cell lysate was
separated by SDS-PAGE and probed with the
indicated antibodies.
(C) A stable Elk1-driven luciferase reporter
cell line was treated with p14 siRNA1, p14
siRNA2, or p14 control sense RNA. Cells were
stimulated for 10 min with EGF or left un-
treated. One aliquot of the cell extract was
used to measure the luciferase activity. The
other aliquot was used to control the protein
amounts of the cell extracts and to determine
the protein levels of endogenous p14 by im-
munoblotting. Tubulin was used as loading
control.
(D) Hela cells, treated with MP1 siRNA or con-
trol sense siRNA were either left starved or
stimulated with EGF for 10 min prior to lysis.
Cell lysate was separated by SDS-PAGE and
probed with the indicated antibodies.
of the endogenous p14 protein to less than 20% as So far it has not been shown that MP1 is required
for the activation of ERK1 in cells. Therefore, we nextcompared to control treated cells, whereas p14 siRNA1
was always less efficient (Figure 2A). Neither the protein examined the effect of MP1 depletion on EGF-induced
MAPK signaling. Efficient reduction of MP1 by MP1levels of MEK1 and ERK1/2 nor MP1 were affected by
the siRNAi treatment (Figure 2A). We next examined siRNAi did not affect the protein levels of endogenous
MEK1/2 and ERK1/2 (Figure 2D), but reduced p14 pro-the effect of the p14 reduction on EGF-induced MAPK
signaling (Figure 2B). After differential reduction of p14 tein levels. The EGF-induced activation of endogenous
MEK1/2 and also of endogenous ERK1/2 was decreasedprotein levels by p14 siRNA1 and p14 siRNA2, EGF-
induced activation of endogenous ERK1/2 decreased after reduction of MP1 protein levels. Interestingly, the
activation of ERK1 seemed to be more defective thanin a p14 concentration-dependent manner (Figure 2B).
Interestingly, activation of endogenous MEK1/2 was the activation of ERK2.
These results indicate that p14 and MP1 are requiredalso slightly reduced. This is consistent with the previ-
ous report on MP1 (Schaeffer et al., 1998), showing that for efficient signal transduction in the ERK cascade.
MP1 also facilitates activation of MEK1 in vitro. Addition-
ally, phosphorylation of RSK, a cytoplasmic target of MP1 Mediates the Interaction of p14
with MEK1 and ERK1ERK1/2 (Chen et al., 1992) was reduced in a p14 concen-
tration-dependent manner (Figure 2B). Nuclear signaling To explore how p14 regulates MAP-kinase signaling, we
investigated the interaction of p14 with the MP1-MAPKof the MAPK pathway was also affected by the reduction
of p14 protein levels, as shown with the Elk1-dependent scaffold module. FLAG-tagged p14 (FLAG-p14) coim-
munoprecipitated endogenous MP1 and endogenousluciferase assay (Figure 2C). Whereas moderate reduc-
tion of p14 by p14 siRNA1 (50% protein knock down MEK1/2 (Figure 3A, lane 4). Although robust amounts
of endogenous MP1 were coimmunoprecipitated, littleefficiency) decreased nuclear MAP kinase signaling to
50% (Figure 2C, lane 3), efficient reduction of p14 to endogenous MEK1/2 could be detected in the immuno-
precipitate (equal amounts of input and FLAG-IP were20% by p14 siRNA2 almost completely abolished the
signaling activity (Figure 2C, lane 4). To test whether loaded). Endogenous ERK1/2 was not detected in the
immunoprecipitate (data not shown).reduction of p14 specifically affects the ERK cascade,
we also tested the activation of the stress MAPK p38. To investigate how and in which order the complex
components bind to each other, we performed complexIntriguingly, reduction of p14 protein levels did not sig-
nificantly affect the phosphorylation of p38 (Figure 2B). reconstitution experiments from Hela cell lysates in vitro.
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Figure 3. p14 Requires MP1 to Associate with MEK1 and ERK1
(A) Flag-p14 was expressed and immunoprecipitated. Beads without antibody and anti-FLAG antibody that was blocked with excess 3Flag
peptide were used as controls. Probing the Flag-p14 immunoprecipitates with the indicated antibodies detected endogenous MP1 and
endogenous MEK1/2. Equal amounts of input and immunoprecipitation are shown.
(B and C) Xpress-tagged p14 (Xp14) was expressed with HA-tagged MEK1 (HA-MEK1) and/or myc-tagged MP1 (myc-MP1). (B) Xp14 was
immunoprecipitated with an anti-Xpress antibody. To demonstrate equal protein expression, cell lysates were probed with anti-HA, anti-myc,
and anti-Xpress antibodies (Input). Probing p14 immunoprecipitates with anti-HA (MEK1) and anti-myc (MP1) antibodies detected interacting
proteins. (C) HA-MEK1 was immunoprecipitated with an anti-HA antibody. The experiment was otherwise performed as in (B).
(D) FLAG-tagged ERK1 (FLAG-ERK1) was coexpressed with Xp14 and/or myc-MP1. FLAG-ERK1 was immunoprecipitated with anti-FLAG
antibody. The experiment was otherwise performed as in (B).
(E) Cells coexpressing FLAG-ERK1 with Xp14 and myc-MP1 were either left starved or stimulated for 10 min with EGF prior to lysis. Anti-
FLAG antibody was used to immunoprecipitate FLAG-ERK1 and the kinase activity was assayed with myelin basic protein (MBP) as substrate.
One representative autoradiograph out of three independent experiments is shown. The statistical evaluation shows the mean  SD of all
three independent experiments.
Hela cells were transiently cotransfected with Xpress- ERK1 (FLAG-ERK1). Immunoprecipitation of Xp14 from
cell extracts of the transfected cells showed that HA-tagged p14 (Xp14), myc-tagged MP1 (myc-MP1), and
either HA-tagged MEK1 (HA-MEK1) or FLAG-tagged MEK1 and myc-MP1 were coimmunoprecipitated in a
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complex (Figure 3B, lane 1). However, Xp14 coimmuno- lower panel). Furthermore, we provide evidence that the
endogenous activated MAPK colocalized with a func-precipitated ectopic MEK1 (HA-MEK1) only in the pres-
ence of ectopic MP1 (myc-MP1; Figure 3B, lane 4). In tional EGFR-GFP fusion-protein (Sorkin et al., 2000; Ver-
veer et al., 2000; Wouters and Bastiaens, 1999) and Xp14the absence of ectopic MP1, Xp14 did not coimmuno-
precipitate HA-MEK1 (Figure 3B, lane 4). In addition, on endosomes (see Supplemental Data available at
http://www.developmentalcell.com/cgi/content/full/3/Xp14 and myc-MP1 were coimmunoprecipitated by HA-
MEK1 (Figure 3C, lane 1). Again, the interaction of ec- 6/803/DC1). In addition to the endosomal localization,
nuclear localization of pERK1/2 was observed after EGFtopic p14 with HA-MEK1 was dependent on the pres-
ence of ectopic MP1 (Figure 3C, lane 3). Similar to the stimulation by epifluorescence microscopy, but the nu-
clear signal was too weak to be imaged by confocalprevious experiments, the interaction of p14 with ERK1
also required MP1 (Figure 3D, lane 1). Interestingly, in the microscopy (Supplemental Data). Consistent with the
complex reconstitution experiments in vitro and thepresence of p14, MP1 seemed to bind more efficiently to
ERK1 (Figure 3D, lane 1 and 3). FLAG-p14 immunoprecipitation, these experiments lead
us to conclude that the p14/MP1-MAPK complex existsp14 and MP1 are crucial for the activation and activity
of ERK1/2 (see Figures 1–2). Thus, p14 and MP1 should in a dynamic fashion on endosomes upon EGF stimu-
lation.be able to influence the kinase activity of immunoiso-
lated ERK1 in vitro. Therefore, we immunoisolated
FLAG-tagged ERK1 from Hela cells either left starved or p14 and MP1 Regulate MAPK Signaling
stimulated with EGF (Figure 3D). Ectopic p14 or ectopic Only on Endosomes
MP1 alone enhanced the kinase activity of the immuno- The colocalization of p14 and MP1 with activated MAPK
isolated activated ERK1 only moderately (Figure 2D, on late endosomes and the results of the in vitro kinase
lanes 3 and 4). However, when both p14 and MP1 were assay suggested that p14 and MP1 might cooperate on
present in the immunoisolated ERK1 complex, the in endosomes to exert their function on MAPK signaling.
vitro ERK1 kinase activity on the substrate MBP was This idea was tested by coexpression of low protein
robustly enhanced (Figure 3D, lane 5). levels of ectopic wild-type p14 together with low levels
Taken together, we provide evidence that p14 has of ectopic MP1 (Figure 5A). Consistent with the result
the potential to associate with endogenous MP1 and shown in Figure 1B, moderate overexpression of p14
MEK1/2. Additionally, it appears likely that MP1 tethers alone did not significantly enhance ERK1/2 activation
p14 to the MEK1/ERK1 module. upon EGF stimulation. (Figure 5A, lane 2). Also, moder-
ate overexpression of MP1 alone did not enhance MAPK
signaling (Figure 5A, lane 4). However, coexpression ofp14 and MP1 Colocalize with Endogenous
the same protein amounts of p14 together with MP1pERK1/2 on Endosomes
(compare protein amounts in Figure 5A, immunoblot:So far, we have shown that p14 is required for EGF-
lanes 2 and 4 with lane 5) significantly enhanced MAPKinduced MAPK signaling and that p14 can be found
activation (Figure 5A, lane 5). It seems that p14 and MP1in a complex with endogenous MP1 and endogenous
exert a cooperative effect on the activation of endoge-MEK1/2. Since we have previously demonstrated that
nous ERK1 but remarkably also on the activation ofp14 and MP1 localize on late endosomes, we next asked
ERK2. To test if the localization of the p14/MP1 complexwhether p14 and MP1 would colocalize with endoge-
would be important for this cooperative effect, we usednous activated MAPK. Cells expressing functional GFP-
the previously described p14caax mutant to mislocalizetagged MP1 (demonstrated in Figure 6A) and Xpress-
p14 to the plasma membrane. This resulted in mislocal-tagged p14 (Xp14) were left untreated or stimulated with
ization of MP1 to the plasma membrane (Wunderlich etEGF. To determine the subcellular localization of the
al., 2001). Whereas coexpression of the endosomal p14/endogenous activated MAPK, we used an antibody that
MP1 complex resulted in a cooperative enhancementrecognizes only the phosphorylated form of ERK1/2.
of ERK1/2 activation (Figure 5A, lane 5), the mislocalizedUsing confocal imaging we analyzed the subcellular dis-
plasma membrane resident p14caax/MP1 complex didtribution of GFP-MP1, Xp14, and endogenous activated
not enhance the activation of MAPK (Figure 5A, laneERK1/2 after 5, 10, or 30 min of EGF stimulation. After
6). To examine whether the late endosomal p14/MP1EGF stimulation neither GFP-MP1 nor Xp14 redistrib-
scaffold complex would also affect nuclear MAPK sig-uted from late endosomes (Figure 4). Importantly,
naling, we performed an Elk1-dependent reporter assay.starved and unstimulated cells showed no significant
Again, only the late endosomal resident p14/MP1 com-pERK1/2 staining (Figure 4, upper panel), indicating that
plex had a cooperative effect on the MAPK pathwaythe antibody specifically recognized the activated form
activity, but not the plasma membrane residentof ERK1/2. However, after 5 min of EGF stimulation, a
p14caax/MP1 complex (Figure 5B, compare lanes 6 andclear increase of pERK1/2 staining was observed mainly
7). Taken together, p14 and MP1 do not affect MAPKin vicinity to the plasma membrane. At this time point, no
signaling at the plasma membrane, but have a coopera-colocalization of pERK1/2 with p14/MP1 on endosomal
tive effect on ERK1/2 activation if properly localized tostructures was observed (Figure 4, second panel). After
late endosomes.10 min of stimulation, the pERK1/2 signal relocalized
from the periphery of the cell toward a perinuclear com-
partment, where phosphorylated ERK1/2 partially colo- p14 Recruits the MAPK Scaffold Protein MP1
to the Late Endosomal Compartmentcalized with p14/MP1 (Figure 4, third panel, white color
indicates colocalization). This colocalization was main- We have shown that the regulatory function of p14 in
the ERK pathway depends on the interaction with MP1tained after 30 min of stimulation with EGF (Figure 4,
Developmental Cell
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Figure 4. pERK1/2 Colocalizes with GFP-MP1 and Xp14
Cells coexpressing GFP-MP1 with Xp14 were left starved or stimulated with EGF for various times prior to fixation. Cells were then subjected
to indirect immunofluorescence analysis using anti-Xpress and anti-pERK1/2 antibodies. Confocal laser scanning analysis was performed.
The pERK1/2 antibody showed no staining in starved cells (EGF). In cells that were stimulated for 10 min or 30 min with EGF colocalization
of pERK1/2 (red) with GFP-MP1 (green) and Xp14 (blue) was detected on perinuclear structures. Inserts show close ups of marked areas.
Colocalization of all three markers is shown in white. Arrows indicate colocalization of GFP-MP1 (green), pERK1/2 (red), and Xp14 (blue) on
individual endosomal structures.
on the membranes of the late endosome. Therefore, Reduction of endogenous p14 did not affect the GFP-
MP1 (Figure 6C) protein levels but resulted in trans-we next asked whether reduction of p14 protein levels
would affect the localization of MP1. For this purpose, location of GFP-MP1 from late endosomes into the
cytoplasm (Figure 6B). Whereas GFP-MP1 localized towe used GFP-MP1 to study the subcellular distribution
of MP1 following the reduction of p14 by p14 siRNAi. perinuclear late endosomes in 75% (n  300) of the
control treated cells, it was mislocalized into the cyto-GFP-MP1 colocalized (Figure 6A, upper panel) and
coimmunoprecipitated (Supplemental Data available at plasm in 72% (n  300) of p14 siRNA2 treated cells
(Figure 6C). The Xpress tagged mouse p14 (Xp14) couldhttp://www.developmentalcell.com/cgi/content/full/3/
6/803/DC1) with Xp14. In addition, Xp14caax recruited not be targeted by siRNAi because it differs in the cDNA
sequence from the human p14 (Figure 6C). Coexpres-GFP-MP1 to the plasma membrane (Figure 6A, lower
panel). Thus, GFP-MP1 resembled the endogenous MP1 sion of Xp14 had no effect on the localization of GFP-
MP1 (Figures 6B and 6C). However, coexpression ofprotein with respect to its localization and its interaction
with p14. Xp14 suppressed the translocation of GFP-MP1 to the
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LAMP1 (Figures 6D and 6E). Although reduction of p14
protein levels caused translocation of GFP-MP1 from
late endosomes into the cytoplasm, the overall organiza-
tion of the endosomal compartment was not disturbed,
as shown by the regular subcellular distribution of
LAMP1 and EEA1 in control and p14 siRNA2 treated
cells. Reduction of p14 did not alter the levels of GFP-
MP1 or the levels of endosomal marker proteins like
EEA1 and LAMP1 (Figure 6F), indicating that the endoso-
mal compartment remained intact. Together these data
strongly suggest that p14 is required and sufficient to
localize MP1 to late endosomes.
p14 Acts as an Adaptor Protein
in the Ras-MAPK Pathway
p14 recruited MP1 to the membranes of late endosomes
(Figure 6) and both proteins cooperatively enhanced
MAPK signaling only when properly localized (Figure 5).
To test whether p14 is necessary for the endosomal
localization of activated ERK1/2, we performed indirect
immunofluorescence analysis using the antibody, which
recognizes only the phosphorylated form of ERK1/2. To
score for cells where p14 protein levels were efficiently
reduced, we took advantage of the fact that GFP-MP1
translocated into the cytoplasm. After 5 min of EGF
stimulation, no colocalization of pERK1/2 with GFP-MP1
was detected (see also Figure 4). Accordingly, no differ-
ence in the pERK1/2 staining in control or p14 siRNA2-
treated cells was observed (Figure 7A, upper panel).
After 10 min of EGF stimulation, pERK1/2 partially colo-
calized with GFP-MP1 in control treated cells. In p14
depleted cells, documented by GFP-MP1 mislocaliza-
tion, strong reduction of the pERK1/2 signal was de-
tected (Figure 7A, lower panel). In addition, cell lysates
were analyzed for ERK1/2 activation at different time
points after EGF stimulation (Figures 7B and 7C). In
control treated cells, ERK1/2 activation became maxi-
mal 10 min after EGF stimulation and started to decline
after 30 min of EGF stimulation. In cells where p14 was
reduced by p14 siRNA2, EGF-induced ERK1/2 activa-
tion was only moderately affected after 5 min of EGF
stimulation. However, after 10 min of EGF stimulation,
ERK1/2 activation was clearly reduced as compared to
the control treated cells. This reduction was maintained
Figure 5. p14 and MP1 on Late Endosomes Have an Additive Effect
after 30 min of EGF stimulation. Together, these dataon MAP Kinase Signaling
suggest that p14 and MP1 are not required for an initial
(A) Cells expressing Xp14, Xp14caax, MP1-myc6, or Xp14 together
phase of MAPK signaling at the plasma membrane, butwith MP1- myc6 and Xp14caax with MP1-myc6 were stimulated for
both p14 and MP1 appear to be required to promote10 min with EGF prior to lysis. Cell lysates were separated by SDS-
PAGE and probed with the indicated antibodies. activation of ERK1/2 on endosomes.
(B) A stable Elk1-driven luciferase reporter Hela cell line was trans-
fected with Xp14, Xp14caax, MP1-myc6, or cotransfected with Xp14 Discussion
together with MP1- myc6 and Xp14caax with MP1-myc6. The experi-
ment was performed as indicated in Figure 1B. DNA constructs were
Signal transduction through the MAPK pathway requirestransfected at the following concentrations: lane 1: empty vector
spatial and temporal specification. The signaling speci-400 ng; lane 2: empty vector 400 ng; lane 3: Xp14 100 ng; lane 4:
Xp14caax 100 ng; lane 5 MP1-myc6 100 ng; lane6 Xp14 100 ng and ficity is regulated by scaffold proteins, which coordinate
MP1-myc6 100 ng; lane 7 p14caax 100 ng and MP1-myc6 100 ng. the assembly of MAPK-signaling units (Catling et al.,
2001; Kolch, 2000). Spatial information is provided by
adaptor proteins, which define the localization of scaf-
fold complexes (Pawson and Scott, 1997).cytoplasm in 55% of the p14 siRNA2 treated cells (n 
300) (Figures 6B and 6C). Our data show that p14 acts as an adaptor protein
that is required and sufficient to localize the MP1-MAPK-In control treated cells, GFP-MP1 did not colocalize
with the early endosomal marker EEA1, but showed the signaling module to late endosomes. The late endo-
somal localization of the p14/MP1-MAPK complex iscorrect colocalization with the late endosomal marker
Developmental Cell
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Figure 6. p14 Is Required for the Localization of MP1 to Late Endosomes
(A) Confocal immunofluorescence analysis of cells expressing GFP-MP1 (green) and Xp14 (red) or GFP-MP1 (green) and Xp14caax (red).
(B, C, D, E, and F) Cells expressing functional GFP-MP1 alone or together with Xp14 were treated with p14 siRNA2 or p14 control sense RNA.
After the siRNAi treatment, cells were trypsinized and seeded again. One part was used for immunofluorescence analysis and the other part
was used to control the p14 knock down efficiency and the expression of GFP-MP1 and Xp14 by immunoblotting.
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Figure 7. p14 Is Required for Endosomal
MAPK Signaling
(A) Cells expressing GFP-MP1 were treated
with control or p14 siRNA2. After stimulation
with EGF, cells were fixed and subjected to
immunofluorescence with anti-pERK1/2 anti-
bodies. After 5 min of EGF stimulation, no
difference between control and siRNA2-
treated was observed. After 10 min of EGF
stimulation, pERK1/2 staining was lost in cells
where GFP-MP1 localized to the cytoplasm
due to reduction of p14 protein levels.
(B) Hela cells, treated with p14 siRNA2 and
control sense RNA, respectively, were either
left starved or stimulated with EGF for 5, 10,
or 30 min prior to lysis. Cell lysate was sepa-
rated by SDS-PAGE and probed with the indi-
cated antibodies.
(C) The graph shows a densitometric analysis
of the ERK1/2 activation. The pERK1/2 sig-
nals were normalized against the ERK1/2
signals.
specifically required for proper signaling in the ERK cas- p14 and MP1 Are Required for Proper
Signaling in the ERK Cascadecade, but not in the p38 pathway. Thus, our findings
unravel a mechanism by which a specific signaling unit Our results provide several lines of evidence that p14
and MP1 are required for signal transduction in the ERKis generated on endosomes to provide specificity as well
as spatial and temporal resolution to the ERK cascade. cascade. We showed a clear correlation between pro-
(B) The localization of GFP-MP1 and Xp14 was determined by epifluorescence microscopy.
(C) A statistical quantification and representative images of the GFP-MP1 and Xp14 localization in p14 siRNA2 and control-treated cells are
shown. Cell lysates were separated by SDS-PAGE and probed with anti-p14, anti-GFP, anti-Xpress antibodies. Control or p14 siRNA2 treated
cells expressing either GFP-MP1 alone or together with Xp14, were scored for the localization of GFP-MP1 (n  300).
(D) Confocal image analysis of the localization of GFP-MP1 (green) and LAMP1 (red); yellow indicates colocalization. In p14 siRNA2 treated
cells, GFP-MP1 does not colocalize with LAMP1 and is mislocalized into the cytoplasm. The subcellular distribution of the LAMP1 positive
late endocytic compartment is not altered.
(E) Confocal image analysis of the localization of GFP-MP1 (green) and EEA1 (red). No colocalization can be observed. In p14 siRNA2 treated
cells, GFP-MP1 is mislocalized to the cytoplasm. The subcellular distribution of the EEA1 positive early endocytic compartment appears
normal.
(F) Cell lysates were separated by SDS-PAGE and probed with anti-p14, anti-GFP, anti-LAMP1, and anti-EEA1 antibodies.
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tein levels of the late endosomal protein p14 and the p14 Is Required and Sufficient to Recruit
the MP1-MAPK Module to the Latesignaling activity of the MAPK pathway upon EGF stimu-
lation. p14 overexpression resulted in a concentration- Endosomal Compartment
Although we did not detect endogenous ERK1/2 in thedependent stimulation of MAPK signaling. Reduction of
p14 protein levels by p14 siRNAi caused mislocalization p14/MP1/MEK complex, we demonstrated that p14 and
MP1 colocalized with endogenous activated ERK1/2 in aof MP1 and a decrease in the activation of MEK1/2,
ERK1, and ERK2. Intriguingly, the activation of the stress dynamic manner on endosomes. Upon EGF stimulation,
ERK1/2 was first activated at the plasma membrane.MAPK p38 was not affected. Futhermore, we showed
that MP1 was also critical for the activation of MEK1/2, Next, the ERK1/2 appeared to be activated on endo-
somes by the internalized EGFR. Subsequently acti-ERK1, and ERK2. These findings appear to be in contrast
to the finding that MP1 promotes signaling from MEK1 vated ERK1/2 colocalized with p14 and MP1 on endo-
somes. Importantly, activated ERK1/2 was found onto ERK1 but not to ERK2 (Schaeffer et al., 1998). Reduc-
tion of MP1 protein levels or mislocalization of MP1, by endosomes but accumulated simultaneously in the nu-
cleus upon EGF stimulation. The time-dependent colo-reduction of p14, might result in a defective cross talk
within the ERK cascade. Therefore, not only the activa- calization of p14 and MP1 with the endogenous acti-
vated kinase provides additional evidence for thetion of ERK1 but also the activation of ERK2 might be
affected. existence of the p14/MP1-MAPK module on the endoso-
mal compartment. Assuming that p14 and MP1 are in-The MAPK scaffold proteins MP1 and KSR directly
interact with signaling kinases. Therefore, they are capa- volved in regulation of MAPK signaling from late endo-
somes, the localization of the p14/MP1 complex shouldble to sequester them, which results in inhibition rather
than in promotion of MAPK signaling. Overexpression be crucial for their regulatory function. Consistent with
this assumption, only a late endosomal p14/MP1 com-of KSR was found either to block or to enhance RAS-
mediated MAPK activation (Roy and Therrien, 2002; plex enhanced MAPK signaling in a cooperative manner,
whereas a mislocalized plasma membrane p14caax/Therrien et al., 1996; Yu et al., 1998). Whereas low KSR
expression levels had a stimulatory effect, high KSR MP1 complex did not. Interestingly, p14caax did not
behave like a dominant-negative mutant. This is mostamounts inhibited MAPK signaling (Cacace et al., 1999).
Schaeffer et al. (1998) demonstrated that, depending on likely due to the fact that p14caax is not able to disrupt
a readily preformed p14/MP1 complex.the relative concentration of MP1, a trimeric MP1/MEK1/
ERK1 signaling module is either favored or disrupted— Importantly, reduction of endogenous p14 resulted
in translocation of MP1 from late endosomes to thetherefore, MAPK signaling is either stimulated or inhib-
ited. These reports emphasize that the relative stoichio- cytoplasm, as well as in inhibition of MAPK signaling.
Interestingly, strong overexpression of MP1 results notmetric amounts of scaffold proteins to the kinases are
crucial for proper signal transduction (Burack and Shaw, only in the reduction of MAPK signaling (Schaeffer et
al., 1998), but also in cytoplasmic mislocalization of MP12000; Levchenko et al., 2000). However, overexpression
of p14 never inhibited MAPK signaling, indicating that (data not shown). Both strong overexpression of MP1
or reduction of p14 result in cytoplasmic accumulationp14 does not disrupt the formation of signaling modules.
Indeed, in vitro complex reconstitution experiments of MP1. This could lead to an unfavorable stoichiometric
relation of cytoplasmic MP1 to MEK and ERK, therebyfrom Hela cell lysates revealed that p14 was not directly
associated with MEK1 and ERK1. p14 required the pres- disrupting signal modules and inhibiting signal trans-
duction.ence of MP1, to be tethered to the signaling module.
Consistently, ectopic p14 could only significantly stimu- Interestingly, in an early phase of signaling, p14 reduc-
tion and mislocalization of MP1 did not affect ERK1/2late in vitro ERK1 kinase activity in the presence of ec-
topic MP1. Additionally, p14 and MP1 exerted a positive activation at the plasma membrane. However, the acti-
vation of ERK1/2 was clearly reduced in a later phasecooperative effect on the activation of endogenous
ERK1/2 in cells. of signaling, when activated ERK1/2 would normally co-
localize with p14 and MP1 on endosomes. Thus, p14p14 interacted robustly with endogenous MP1 and
coimmunoprecipitated small amounts of endogenous and MP1 are required for the activation of ERK1/2 on
endosomes, but not at the plasma membrane.MEK1/2. However, endogenous ERK1/2 was not de-
tected in the immunoprecipitate. The association of the An attractive explanation to this time- and space-
dependent effect would be that signaling molecules arep14/MP1 complex with MEK1/2 and ERK1/2 could be
very transient. The reason for this short-lived interaction assembled in different scaffold complexes that are
formed at different times in distinct subcellular loca-might be due to the intrinsic nature of MEK to ERK
signaling. Previously, it has been reported that the inter- tions.
On the one hand, the p14/MP1 complex is requiredaction of ERK with its upstream effector MEK has to be
transient in order to allow nuclear accumulation of ERK to promote MAPK signaling from late endosomes. On
the other hand, KSR under the control of C-TAK1, regu-in response to stimulation of the signaling cascade (Ada-
chi et al., 1999, 2000; Khokhlatchev et al., 1998). There- lates the formation of a MAPK signaling unit at the
plasma membrane upon EGF stimulation (Muller et al.,fore, a long-lived p14/MP1/MEK1/ERK1 complex should
be unfavorable for efficient MAPK signaling. A stable 2001; Roy et al., 2002). The formation of such mem-
brane-based scaffold complexes would be ideal for theinteraction would capture MEK and ERK together in a
complex, thereby preventing the transmission of down- propagation of signals with high spatial as well as tem-
poral resolution and specificity within cells (Kholodenko,stream signaling and nuclear accumulation of ERK.
Taken together, the p14/MP1 complex is required for 2002, 2000).
Specific signaling modules on distinct subcellularproper signaling in the ERK cascade.
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buffer (50 mM Tris-HCl, 200 mM NaCl, 1% Triton X-100, 10% glyc-compartments could provide spatial and temporal infor-
erol, 5 mM Na4P2O7, 2 mM Na3OV4, 50 mM NaF, 20 mM -glycero-mation to modulate the output of MAPK signaling. It is
phosphate, and protease inhibitors). For the kinase assay, FLAG-tempting to speculate that signaling units on endo-
ERK1 was immunoprecipitated with anti-FLAG antibody. Beads
somes created through the interplay of the adaptor p14 were washed three times in IP-buffer (without EGTA and EDTA) and
and the scaffold MP1 might be required for the genera- two times in kinase reaction buffer (50 mM HEPES [pH 7.4], 10 mM
MgOCH3COOH, and 1 mM DTT). For the in vitro phosphorylation, 2tion of a specific biological response. Consequently, it
g MBP, 5 M ATP and 20 Cui [32]ATP were used for 30min atwill be important to study the physiological role of p14,
30C; for the phospho-MAPK analysis, the protein concentrationMP1, and of endosomal signaling in the development
was measured and equal amounts of protein were used for the SDS-of an organism.
PAGE.
Ultimately, our findings emphasize how the localiza-
tion of signaling units, rather than the direct modulation Luciferase Assay
of the enzymatic activity of the kinases within the cas- The luciferase assays were performed using the stable PathDetect
Trans-Reporter Cell Lines from Stratagene according to the manu-cade, can exert regulatory function to signal trans-
facturer’s instructions. After transfection, cells were serum starvedduction.
for 16 hr in DMEM. Cells were stimulated for 10 min with 100 ng/ml
EGF in DMEM. After the stimulation, the EGF containing DMEM wasExperimental Procedures
washed twice with DMEM. Cells were harvested and lysed 3 hr after
the stimulation. One aliquot of the cell extract was used to measureAntibodies and Reagents
the luciferase activity. The other aliquot was used to control proteinThe phospho-ERK1/2, phospho-MEK1/2, phospho-RSK, phospho-
expression and total protein amounts by immunoblotting; transferrinp38, ERK1/2,MEK1/2, and p38 antibodies were obtained from Cell
receptor (TfR) was used as a loading control. DNA constructs wereSignaling (Berverly, MA). The Flag epitop antibody and the 	-tubulin
transfected at the different concentrations. The empty pEF4/HisCantibody were purchased from Sigma (St.Louis, MO). The Xpress
(Invitrogen) vector was used to keep the total DNA concentrationantibody was obtained from Invitrogen, the HA antibody from Babco,
at 400 ng/well.the myc antibody from Gramsch Laboratories, the GFP antibody
from Roche, and the human CD107a (LAMP1) antibody from Phar-
Immunofluorescencemingen. The EEA1 antibody was obtained from the laboratory of M.
Hela cells were either left untreated or stimulated with 100 ng/mlZerial. The Alexa 488, Alexa 568, and Alexa 647 secondary antibod-
EGF after starvation for 16 hr. Cells were immediately fixed for 10ies were obtained from Molecular Probes.
min on ice with ice-cold 4% paraformaldehyde in cytoskeleton buffer
(CB) (10 mM Pipes [pH 6.8], 150 mM NaCl, 5 mM EGTA, 5 mMGeneration of siRNAi and DNA Constructs
glucose, 5 mM MgCl2, 5 mM Na4P2O7, 2 mM Na3OV4, 50 mM NaF,p14 siRNA1 targets the sequence AACAUCUGGGCCGCCUACGAC
20 mM -glycerophosphate). Next, cells were permeablized in 0.2%and p14 siRNA2 targets the sequence AAGGAGACCGUGGGCUU
Triton X-100 in CB. Cells were incubated for 2 hr with the primaryUGGA on the human p14 mRNA. MP1 siRNA targets the sequence
antibody (anti phospho MAPK antibody, rabbit poly-clonal from CellAACACCUACCAGGUGGUUCAA on the human MP1 mRNA. Except
Signaling, diluted 1:100), washed five times in CB and 50 mM NH4Cl,for p14 or MP1, no other mRNAs in the NCBI database contained
incubated for forty minutes with the secondary (Alexa-labeled) anti-the specific sequences. RNA oligonucleotides were purchased from
body, washed five times in CB and 50 mM NH4Cl and mounted inDharmacon and used as described (Elbashir et al., 2001). RNA du-
Mowiol. Confocal image analysis was performed using a Zeiss LSMplexes were transfected using Oligofectamine (Invitrogen). Cells
510 Confocal Laser Scanning Microscope.were incubated for 5 hr with the RNA duplex or the sense RNA as
a control. Then the transfection reagent was washed off. The knock
down of p14 and MP1 protein amounts was observed after 32 hr. Acknowledgments
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